Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
5–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have haemophilia A or B with inhibitors to factor VIII or IX, respectively
Have had a historical inhibitor level of at least five Bethesda units or have had an inadequate haemostatic response to 250 U/kg of factor VIII or IX or have had an inadequate response to FEIBA
Require pre-planned major surgery in hospital
You may not be if
Have participated in or have been treated with any investigational drug other than activated recombinant human factor VII within the last thirty days
Have been treated with any haemostatic agent, including rFVIIa, within 48 hours of preoperative dose
Have any haemostatic disorder other than haemophilia
Clareo Health | Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery
